Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Disease crawled time : 18:00 save search
Nektar Management to Present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference
Published: 2024-03-22 (Crawled : 18:00) - prnewswire.com
NKTR | News | $1.295 -4.07% 1.1M
|
Health Technology
| Email alert
Add to watchlist
management conference disease
Global OTC/DTC Infectious Disease Diagnostics Market Research Report 2024 with Guides for Executives and Marketing Staff, & Investment Analysts and Management Consultants
Published: 2024-03-21 (Crawled : 18:00) - prnewswire.com
TMO | News | $542.71 -0.83% 1.2M
|
Health Technology
|
| O: -0.01%
H: 1.22%
C: 0.71%
BDX | $230.84 -0.59% 300K
|
Health Technology
|
| O: 0.46%
H: 1.26%
C: 1.11%
OSUR | $5.315 1.24% 110K
|
Health Technology
|
| O: -0.15%
H: 1.08%
C: -2.61%
management disease report research global diagnostics market
Gain Therapeutics Announces 2024 R&D Update on Parkinson’s Disease with KOL & Analyst Insight
Published: 2024-02-14 (Crawled : 18:00) - globenewswire.com
GANX | $3.24 1.89% 35K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 5.32%
C: 4.88%
disease update parkinson’s therapeutics
Global Molecular Diagnostics Market for Infectious Disease Research Report 2024: Syndrome, Plex, Place and Country Breakdown with Executive Guides - Forecasts and Analysis 2023-2027
Published: 2024-02-13 (Crawled : 18:00) - prnewswire.com
TMO | News | $542.71 -0.83% 1.2M
|
Health Technology
|
| O: -0.99%
H: 0.88%
C: -0.52%
ABT | News | $104.91 -0.94% 2.8M
|
Health Technology
|
| O: 0.94%
H: 0.0%
C: 0.0%
disease report research global diagnostics molecular market
Veracyte Announces Preliminary Full-Year 2023 Results, Acquisition of C2i Genomics to Add Minimal Residual Disease Capabilities to Its Novel Diagnostics Platform
Published: 2024-01-08 (Crawled : 18:00) - biospace.com/
MS | News 0 d | $90.79 0.79% 1.7M
|
Finance
|
| O: -0.03%
H: 0.67%
C: 0.32%
VCYT | $19.215 1.88% 250K
|
Health Technology
|
| O: 2.53%
H: 10.54%
C: 10.31%
disease genomics acquisition diagnostics platform
Abstract for ENDRA Life Sciences' TAEUS System Accepted for Presentation at EASL Steatotic Liver Disease Summit 2023
Published: 2023-09-07 (Crawled : 18:00) - biospace.com/
NDRA | $0.2426 5.11% 41K
|
Health Technology
|
| O: 0.0%
H: 4.59%
C: 3.68%
liver disease taeus life presentation system
Veopoz™ (pozelimab-bbfg) Receives FDA Approval as the First Treatment for Children and Adults with CHAPLE Disease
Published: 2023-08-18 (Crawled : 18:00) - globenewswire.com
SNYNF | News | $92.7 1.4K
|
Health Technology
|
| O: 1.52%
H: 0.0%
C: 0.0%
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: -0.73%
H: 0.0%
C: 0.0%
REGN | $900.22 -0.11% 150K
|
Health Technology
|
| O: -0.39%
H: 3.29%
C: 2.21%
fda disease children approval treatment
Allen Institute for Immunology partners with Lilly to better understand autoimmune disease
Published: 2023-07-18 (Crawled : 18:00) - biospace.com/
LLY | News | $749.245 -0.2% 550K
|
Health Technology
|
| O: -0.04%
H: 1.43%
C: 0.95%
institute disease immunology
THE AHEAD STUDY IS TESTING LECANEMAB AT THE STAGE OF PRECLINICAL ALZHEIMER'S DISEASE
Published: 2023-07-11 (Crawled : 18:00) - biospace.com/
BIIB | $191.72 -0.23% 370K
|
Health Technology
|
| O: -0.56%
H: 0.19%
C: -0.06%
disease lecanemab preclinical alzheimer's study
Lilly Announces Webcast to Provide Alzheimer's Disease Update at AAIC
Published: 2023-07-11 (Crawled : 18:00) - biospace.com/
LLY | News | $749.245 -0.2% 550K
|
Health Technology
|
| O: -0.7%
H: 0.12%
C: -2.36%
disease update alzheimer's aaic
TEPEZZA® (teprotumumab) Approved in Brazil for the Treatment of Active Thyroid Eye Disease (TED)
Published: 2023-06-26 (Crawled : 18:00) - biospace.com/
HZNP | $116.3 0.03% 29M
|
Health Technology
|
| O: -0.43%
H: 0.48%
C: 0.38%
tepezza disease active approved treatment thyroid brazil eye
New Phase 2 Data Demonstrate Potential Benefit of Nipocalimab for Pregnant Individuals at High Risk of Early-Onset Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
Published: 2023-06-26 (Crawled : 18:00) - biospace.com/
JNJ | News | $144.86 0.06% 2.8M
|
Health Technology
|
| O: -0.3%
H: 0.0%
C: -0.82%
disease risk potential
Galera Presents Additional Chronic Kidney Disease Data from ROMAN Trial at 2023 ASCO Annual Meeting
Published: 2023-06-05 (Crawled : 18:00) - globenewswire.com
GRTX | $0.194 -2.22% 2.6M
|
Health Technology
|
| O: -0.32%
H: 1.12%
C: -2.24%
disease kidney asco meeting trial
Study Helps Explain What Drives Psoriasis Severity and Offers Clues as to How Disease May Spread to Other Body Parts
Published: 2023-06-02 (Crawled : 18:00) - prnewswire.com
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 1.4K
|
Health Technology
| Email alert
Add to watchlist
disease psoriasis study
Phase 2 Data from “ASTRAEUS” Trial of Mereo BioPharma’s Alvelestat in Alpha-1 Antitrypsin Deficiency-associated Lung Disease Presented at the 2023 American Thoracic Society International Conference
Published: 2023-05-23 (Crawled : 18:00) - globenewswire.com
MREO | $2.635 2.13% 290K
|
Health Technology
|
| O: 0.0%
H: 6.25%
C: -5.47%
lung conference disease international alvelestat trial
Global Gaucher's Disease Treatment Market Research Report 2023: Emerging Therapies, Clinical Trials, Treatments, Current Scenario Evaluation, Patient Profile
Published: 2023-05-10 (Crawled : 18:00) - prnewswire.com
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.92%
H: 0.0%
C: 0.0%
TAK | $13.185 0.27% 570K
|
Health Technology
|
| O: -1.83%
H: 0.12%
C: -3.06%
NVS | News | $92.61 -0.51% 430K
|
Health Technology
|
| O: -0.4%
H: 0.34%
C: 0.19%
JNJ | News | $144.86 0.06% 2.8M
|
Health Technology
|
| O: 0.11%
H: 0.22%
C: -0.52%
ABT | News | $104.91 -0.94% 2.8M
|
Health Technology
|
| O: -0.57%
H: 0.37%
C: -0.01%
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: -0.28%
H: 0.0%
C: 0.0%
disease report treatment research global market
Amicus Therapeutics Receives Positive CHMP Opinion for Opfolda® (miglustat) for Late-Onset Pompe Disease
Published: 2023-04-26 (Crawled : 18:00) - globenewswire.com
FOLD F | $10.44 -1.04% 270K
|
Health Technology
|
| O: -0.61%
H: 3.14%
C: 0.7%
opfolda disease chmp positive therapeutics
HDL Therapeutics Inc Plans to Become Publicly Traded via a Business Combination With $225 Million Swiftmerge (NASDAQ : IVCP) With Goal to Transform Cardiovascular Disease Treatment – Marketscreener.com
Published: 2023-04-24 (Crawled : 18:00) - spacfeed.com
MODD 4 | $1.71 0.59% 21K
|
|
| O: -1.05%
H: 1.86%
C: 1.86%
disease business treatment therapeutics cardiovascular
Orchard Therapeutics to Present at Guggenheim Genomic Medicines and Rare Disease Day
Published: 2023-03-30 (Crawled : 18:00) - biospace.com/
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 1.44%
H: 0.0%
C: -2.08%
day rare disease genomic therapeutics
Aldeyra Therapeutics Advances Investigational Oral RASP Modulator ADX‑629 Into New Phase 2 Systemic Disease Trials
Published: 2023-02-16 (Crawled : 18:00) - biospace.com/
ALDX 4 | $4.01 1.01% 210K
|
Health Technology
|
| O: -1.09%
H: 8.6%
C: 6.62%
trials disease therapeutics phase 2
Gainers vs Losers
| 79% | 21% |
Top 10 Gainers
AGBA | $0.7995 99.88% 73M
|
Finance
BPTH | $6.21 91.67% 58M
|
Health Technology
INVO | $1.36 78.95% 3.6M
|
Health Technology
TIRX | $0.8231 69.78% 54M
|
ISPC | $0.307 44.13% 3.6M
|
Professional, Scientific, and T...
SINT | $0.0519 39.14% 350M
|
Health Technology
XPON | $2.63 36.27% 8.4M
|
ALRN | $5.53 30.12% 250K
|
Health Technology
VTNR S | $1.26 28.68% 9.1M
|
Industrial Services
HOLO | $2.86 27.68% 28M
|
Your saved searches
Save your searches and get alerts when important news are released.